Whitney Page

Whitney Page is a biopharmaceutical executive with over 15 years of experience in corporate development, alliance management, business development, and clinical development across the drug development lifecycle and through key stages of company growth. Prior to joining Slate, Whitney held senior roles at Syndax Pharmaceuticals, Verona Pharma (acquired by Merck), and G1 Therapeutics (acquired by Pharmacosmos). In these roles she partnered closely with cross-functional teams and leadership to build strategic partnerships, navigate complex transactions, and help organizations actualize goals. Whitney holds a Bachelor of Business Administration degree in Marketing and Economics from Marshall University.